Peter Justin Klein
CIK 1608710 · last filed 2021-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.65M
Companies
2
Total Filings
26
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | 2,303 | $0.07 | $161 | $0 | 5 | 2021-06-04 |
| SENS | Director | 369,186 | $7.18 | $2.65M | $0 | 21 | 2021-04-05 |
Recent Filings · Page 3 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-01 | SENS | Grant (A) | — | $0 | EDGAR |
| 2018-04-09 | SENS | Grant (A) | +3,911 | $12.1K | EDGAR |
| 2018-01-04 | SENS | Grant (A) | +4,558 | $12.1K | EDGAR |
| 2017-10-16 | SENS | Grant (A) | +4,041 | $0 | EDGAR |
| 2017-05-26 | SENS | Grant (A) | — | $0 | EDGAR |
| 2016-05-26 | SENS | Grant (A) | — | $0 | EDGAR |
Showing 21–26 of 26
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.